<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629835</url>
  </required_header>
  <id_info>
    <org_study_id>MontrealGH</org_study_id>
    <nct_id>NCT02629835</nct_id>
  </id_info>
  <brief_title>Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks</brief_title>
  <official_title>A Randomized Comparison Between Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montreal General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexamethasone prolong the duration of brachial plexus blocks, but the optimal route,
      intravenous (IV) or perineural (PN), remains controversial.

      This Multi-centric trial compare IV and PN dexamethasone for ultrasound-guided axillary
      brachial plexus blocks (AXBs). Research hypothesis is that PN modality will outlast its IV
      counterpart. Since analgesic duration and sensory duration can be influenced by intake of
      pain medications and surgical trauma to small cutaneous nerves, the investigators will select
      motor block duration as the main outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After Ethics Committee of the McGill University Health Centre, a total of 150 patients
      undergoing upper extremity surgery (below the elbow) will be recruited.

      All AXBs will be supervised by one of the coauthors and conducted preoperatively in an
      induction room. This area will have full access to an oxygen source, resuscitative equipment
      and drugs.

      All patients will have fasted for at least eight hours. An IV cannula will be placed prior
      the block and will be monitored and given oxygen at 2-4 L/min through nasal cannulas.

      Light sedation will be provided for patient comfort if needed.Patients will be placed supine
      with the shoulder abducted and the elbow flexed. The AXB will have a puncture site superior
      to the axillary artery. After skin disinfection and draping, a skin wheal will be raised with
      3 mL of lidocaine 1.5%.

      In both groups, 30 mL of lidocaine 1.0%-bupivacaine 0.25% with epinephrine 5 µ/mL will be
      used. A 22-gauge, 5 cm block will be advanced under direct US vision toward the
      musculocutaneous nerve. Six mL of LA will be deposited in this location. The needle will then
      be directed posterior to the artery, at 6 o'clock position and twenty-four mL of LA will be
      deposited to obtain a spread around the artery.

      Patients will be randomized to receive 8 mg of IV or PN dexamethasone. In the IV group,
      patients will receive 0.8 mL of dexamethasone (10 mg/mL) intravenously and 0.8 mL of normal
      saline will be added to the injectate through the block needle. In the PN group, patients
      will receive 0.8 mL of normal saline intravenously and 0.8 mL of dexamethasone (10 mg/mL)
      will be added to the injectate through the block needle.

      A research assistant will prepare the IV and PN injectates. The operator, patient and
      investigator assessing the block will be blinded to group allocation.

      If placement of the needle tip in the desired location is unsuccessful after 15 minutes, the
      procedure will be stopped and the patient excluded from the study. Brachial plexus blockade
      will be carried out using an alternative method. If the alternative method fails as well, the
      patient will be given general anesthesia and intravenous narcotics will be used for
      postoperative analgesia
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motor block duration</measure>
    <time_frame>24 hours</time_frame>
    <description>Duration of the motor block (defined as the temporal interval between the end of LA injection through the block needle and the return of movement to the hand and fingers). Patient is contacted at the next day of the surgery and asked about the time when the motor block started to disappear.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of the sensory block</measure>
    <time_frame>24 hours</time_frame>
    <description>defined as the temporal interval between the end of LA injection through the block needle and the return of sensation to the hand and fingers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesia duration</measure>
    <time_frame>24 hours</time_frame>
    <description>defined as the temporal interval between the end of LA injection through the block needle and the appearance of pain at the surgical site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset time</measure>
    <time_frame>30 minutes</time_frame>
    <description>Time required to reach a minimal score of 14 points of a total of 16. Sensory blockade will be graded according to a 3-point scale using a cold test: 0 = no block, 1 = analgesia (patient can feel touch, not cold), 2 = anesthesia (patient cannot fee touch). The cold test will be applied with light touch to avoid confusion with deep pressure sensation.
Motor blockade will also be graded on a 3-point scale: 0 = no block, 1 = paresis, 2 = paralysis (19). Motor blockade of the musculocutaneous, radial, median and ulnar nerves will be evaluated by elbow flexion (musculocutaneous), thumb abduction (radial), thumb opposition (median) and thumb adduction (ulnar).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate</measure>
    <time_frame>30-60 minutes</time_frame>
    <description>Ability to proceed with surgery without the need for intravenous narcotics, general anesthesia, rescue blocks or LA infiltration by the surgeon. Just propofol based sedation (25-80 μg/kg/min) will be permitted if necessary, keeping always response to verbal stimulus.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Demographic data</measure>
    <time_frame>30 minutes</time_frame>
    <description>sex, age, weight, height, type of surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects</measure>
    <time_frame>30-60 minutes</time_frame>
    <description>vascular puncture, hematoma at the site of puncture, toxic effects of LA</description>
  </other_outcome>
  <other_outcome>
    <measure>Persistent deficit</measure>
    <time_frame>7 days</time_frame>
    <description>All patients will be contacted after 7 days by a blinded observer asking about persistent sensory or motor deficit in relation with the blocked nerves.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Brachial Plexus Block Duration</condition>
  <arm_group>
    <arm_group_label>Intravenous dexamethasone 8 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving intravenous 8 mg of dexamethasone in parallel to ultrasound guided axillary nerve block with a standardized local anesthetic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perineural dexamethasone 8 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient receiving perineural 8 mg of dexamethasone in a mixture with a standardized local anesthetic solution for ultrasound guided axillary block</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intravenous 8 mg dexamethasone and perineural 0.8 ml of saline solution</intervention_name>
    <arm_group_label>Intravenous dexamethasone 8 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intravenous 0,8 ml of saline solution and perineural 8 mg of dexamethasone</intervention_name>
    <arm_group_label>Perineural dexamethasone 8 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Below Elbow surgery

          -  Age between 18 and 80 years

          -  American Society of Anesthesiologists classification 1-3

          -  Body mass index between 18 and 35 kg/m2

        Exclusion Criteria:

          -  Adults who are unable to give their own consent

          -  Pre-existing neuropathy (assessed by history and physical examination)

          -  Coagulopathy (assessed by history and physical examination and, if deemed clinically
             necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4
             or partial prothrombin time ≥ 50)

          -  Renal failure (assessed by history and physical examination and, if deemed clinically
             necessary, by blood work up i.e. creatinine ≥ 100)

          -  Hepatic failure (assessed by history and physical examination and, if deemed
             clinically necessary, by blood work up i.e. transaminases ≥ 100)

          -  Allergy to local anesthetics (LAs)

          -  Pregnancy

          -  Prior surgery in the axillary region

          -  Chronic pain syndromes requiring opioid intake at home
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>De QH Tran, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montreal General Hospital, McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ramathibodi Hospital, Mahidol University,</name>
      <address>
        <city>Bangkok</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Chiang Mai</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Persec J, Persec Z, Kopljar M, Zupcic M, Sakic L, Zrinjscak IK, Marinic DK. Low-dose dexamethasone with levobupivacaine improves analgesia after supraclavicular brachial plexus blockade. Int Orthop. 2014 Jan;38(1):101-5. doi: 10.1007/s00264-013-2094-z. Epub 2013 Sep 6.</citation>
    <PMID>24173676</PMID>
  </reference>
  <results_reference>
    <citation>Vieira PA, Pulai I, Tsao GC, Manikantan P, Keller B, Connelly NR. Dexamethasone with bupivacaine increases duration of analgesia in ultrasound-guided interscalene brachial plexus blockade. Eur J Anaesthesiol. 2010 Mar;27(3):285-8. doi: 10.1097/EJA.0b013e3283350c38.</citation>
    <PMID>20009936</PMID>
  </results_reference>
  <results_reference>
    <citation>Tandoc MN, Fan L, Kolesnikov S, Kruglov A, Nader ND. Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. J Anesth. 2011 Oct;25(5):704-9. doi: 10.1007/s00540-011-1180-x. Epub 2011 Jun 17.</citation>
    <PMID>21681533</PMID>
  </results_reference>
  <results_reference>
    <citation>Cummings KC 3rd, Napierkowski DE, Parra-Sanchez I, Kurz A, Dalton JE, Brems JJ, Sessler DI. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. Br J Anaesth. 2011 Sep;107(3):446-53. doi: 10.1093/bja/aer159. Epub 2011 Jun 14.</citation>
    <PMID>21676892</PMID>
  </results_reference>
  <results_reference>
    <citation>Kawanishi R, Yamamoto K, Tobetto Y, Nomura K, Kato M, Go R, Tsutsumi YM, Tanaka K, Takeda Y. Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local Reg Anesth. 2014 Apr 5;7:5-9. doi: 10.2147/LRA.S59158. eCollection 2014.</citation>
    <PMID>24817819</PMID>
  </results_reference>
  <results_reference>
    <citation>Shrestha BR, Maharjan SK, Tabedar S. Supraclavicular brachial plexus block with and without dexamethasone - a comparative study. Kathmandu Univ Med J (KUMJ). 2003 Jul-Sep;1(3):158-60.</citation>
    <PMID>16388222</PMID>
  </results_reference>
  <results_reference>
    <citation>Yadav RK, Sah BP, Kumar P, Singh SN. Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: A prospective, randomized, double blinded, controlled study. Kathmandu Univ Med J (KUMJ). 2008 Jul-Sep;6(23):302-9.</citation>
    <PMID>20071811</PMID>
  </results_reference>
  <results_reference>
    <citation>Parrington SJ, O'Donnell D, Chan VW, Brown-Shreves D, Subramanyam R, Qu M, Brull R. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus blockade. Reg Anesth Pain Med. 2010 Sep-Oct;35(5):422-6. doi: 10.1097/AAP.0b013e3181e85eb9.</citation>
    <PMID>20814282</PMID>
  </results_reference>
  <results_reference>
    <citation>Biradar PA, Kaimar P, Gopalakrishna K. Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: A prospective, randomised, double-blind study. Indian J Anaesth. 2013 Mar;57(2):180-4. doi: 10.4103/0019-5049.111850.</citation>
    <PMID>23825819</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdallah FW, Johnson J, Chan V, Murgatroyd H, Ghafari M, Ami N, Jin R, Brull R. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2015 Mar-Apr;40(2):125-32. doi: 10.1097/AAP.0000000000000210. Erratum in: Reg Anesth Pain Med. 2015 Jul-Aug;40(4):398.</citation>
    <PMID>25629321</PMID>
  </results_reference>
  <results_reference>
    <citation>Movafegh A, Razazian M, Hajimaohamadi F, Meysamie A. Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesth Analg. 2006 Jan;102(1):263-7.</citation>
    <PMID>16368840</PMID>
  </results_reference>
  <results_reference>
    <citation>Yaghoobi S, Seddighi M, Yazdi Z, Ghafouri R, Khezri MB. Comparison of Postoperative Analgesic Effect of Dexamethasone and Fentanyl Added to Lidocaine through Axillary Block in Forearm Fracture. Pain Res Treat. 2013;2013:761583. doi: 10.1155/2013/761583. Epub 2013 Dec 29.</citation>
    <PMID>24490067</PMID>
  </results_reference>
  <results_reference>
    <citation>Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, Carlier S, Missant C, Van de Velde M. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013 Sep;111(3):445-52. doi: 10.1093/bja/aet109. Epub 2013 Apr 15.</citation>
    <PMID>23587875</PMID>
  </results_reference>
  <results_reference>
    <citation>Tran DQ, Bertini P, Zaouter C, Muñoz L, Finlayson RJ. A prospective, randomized comparison between single- and double-injection ultrasound-guided infraclavicular brachial plexus block. Reg Anesth Pain Med. 2010 Jan-Feb;35(1):16-21. doi: 10.1097/AAP.0b013e3181c7717c.</citation>
    <PMID>20048654</PMID>
  </results_reference>
  <results_reference>
    <citation>González AP, Bernucci F, Pham K, Correa JA, Finlayson RJ, Tran DQ. Minimum effective volume of lidocaine for double-injection ultrasound-guided axillary block. Reg Anesth Pain Med. 2013 Jan-Feb;38(1):16-20. doi: 10.1097/AAP.0b013e3182707176.</citation>
    <PMID>23146999</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal General Hospital</investigator_affiliation>
    <investigator_full_name>De QH Tran</investigator_full_name>
    <investigator_title>Associate Profesor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

